AAAAAA
Results:
1-14
|
Results: 14
Authors:
ANCEREWICZ J
MIGLIAVACCA E
CARRUPT PA
TESTA B
BREE F
ZINI R
TILLEMENT JP
LABIDALLE S
GUYOT D
CHAUVETMONGES AM
CREVAT A
LERIDANT A
Citation: J. Ancerewicz et al., STRUCTURE-PROPERTY RELATIONSHIPS OF TRIMETAZIDINE DERIVATIVES AND MODEL COMPOUNDS AS POTENTIAL ANTIOXIDANTS, Free radical biology & medicine, 25(1), 1998, pp. 113-120
Authors:
ELIMADI A
MORIN D
SAPENA R
CHAUVETMONGES AM
CREVAT A
TILLEMENT JP
Citation: A. Elimadi et al., COMPARISON OF THE EFFECTS OF CYCLOSPORINE-A AND TRIMETAZIDINE ON CA2-DEPENDENT MITOCHONDRIAL SWELLING(), Fundamental and clinical pharmacology, 11(5), 1997, pp. 440-447
Authors:
SIMON N
BRUNET P
ROUMENOV D
DUSSOL B
BARRE J
DUCHE JC
ALBENGRES E
DATHIS P
CHAUVETMONGES AM
BERLAND Y
TILLEMENT JP
Citation: N. Simon et al., TRIMETAZIDINE DOES NOT MODIFY BLOOD-LEVELS AND IMMUNOSUPPRESSANT EFFECTS OF CYCLOSPORINE-A IN RENAL-ALLOGRAFT RECIPIENTS, British journal of clinical pharmacology, 44(6), 1997, pp. 591-594
Authors:
ALBENGRES E
LELOUET H
CHAUVETMONGES AM
ALLAIN V
CREVAT A
TILLEMENT JP
Citation: E. Albengres et al., RESTORATION OF MITOCHONDRIAL ATP SYNTHESIS AS A POTENTIAL TARGET FOR LIMITING CYCLOSPORINE (CSA)-INDUCED NEPHROTOXICITY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 2-2
Authors:
ELIMADI A
MORIN D
ALBENGRES E
CHAUVETMONGES AM
ALLAIN V
CREVAT A
TILLEMENT JP
Citation: A. Elimadi et al., DIFFERENTIAL-EFFECTS OF ZIDOVUDINE AND ZIDOVUDINE TRIPHOSPHATE ON MITOCHONDRIAL PERMEABILITY TRANSITION AND OXIDATIVE-PHOSPHORYLATION, British Journal of Pharmacology, 121(7), 1997, pp. 1295-1300
Authors:
BERLAND Y
CARLES G
TABOUY L
CHAUVETMONGES AM
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM COUNTERACTS THE IN-VITRO CYTOTOXICITY OF CELLULOSE-ACETATE EXTRACTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1120-1120
Authors:
ALBENGRES E
TILLEMENT JP
DATHIS P
SALDUCCI D
CHAUVETMONGES AM
CREVAT A
Citation: E. Albengres et al., LACK OF PHARMACODYNAMIC INTERACTION BETWEEN TRIMETAZIDINE AND CYCLOSPORINE-A IN HUMAN LYMPHOPROLIFERATIVE AND MOUSE DELAYED-HYPERSENSITIVITY RESPONSE MODELS, Fundamental and clinical pharmacology, 10(3), 1996, pp. 264-268
Authors:
SALDUCCI MD
CHAUVETMONGES AM
TILLEMENT JP
ALBENGRES E
TESTA B
CARRUPT P
CREVAT A
Citation: Md. Salducci et al., TRIMETAZIDINE REVERSES CALCIUM ACCUMULATION AND IMPAIRMENT OF PHOSPHORYLATION-INDUCED BY CYCLOSPORINE-A IN ISOLATED RAT-LIVER MITOCHONDRIA, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 417-422
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
GARCIA P
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM IMPROVES IN-VITRO MITOCHONDRIAL BIOCOMPATIBILITY OF HEMODIALYSERS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 482-482
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
GARCIA P
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM IMPROVES IN-VITRO MITOCHONDRIAL BIOCOMPATIBILITY OF HEMODIALYSERS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 520-520
Authors:
SALDUCCI MD
CHAUVETMONGES AM
DUSSOL BM
BERLAND YF
CREVAT AD
Citation: Md. Salducci et al., IS THE BENEFICIAL EFFECT OF CALCIUM-CHANNEL BLOCKERS AGAINST CYCLOSPORINE-A TOXICITY RELATED TO A RESTORATION OF ATP SYNTHESIS, Pharmaceutical research, 12(4), 1995, pp. 518-522
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., MITOCHONDRIA AS AN IN-VITRO TEST OF HEMODIALYSER BIOCOMPATIBILITY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 433-433
Authors:
TABOUY L
CHAUVETMONGES AM
SALDUCCI MD
CREVAT A
Citation: L. Tabouy et al., PROTECTIVE EFFECT OF SOME CALCIUM-ANTAGONISTS AGAINST MITOCHONDRIAL CALCIUM INJURY, International journal on tissue reactions, 16(5-6), 1994, pp. 221-228
Authors:
UBEAUD G
CHAUVETMONGES AM
MONTI JP
TILLEMENT JP
CREVAT A
Citation: G. Ubeaud et al., CALCIUM ANTI-IONOPHORETIC EFFECT OF SOME CALCIUM-CHANNEL BLOCKERS IN RAT-LIVER MITOCHONDRIA, Journal of pharmaceutical sciences, 83(2), 1994, pp. 165-168
Risultati:
1-14
|